BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17426142)

  • 21. 2.4 A resolution crystal structure of the prototypical hormone-processing protease Kex2 in complex with an Ala-Lys-Arg boronic acid inhibitor.
    Holyoak T; Wilson MA; Fenn TD; Kettner CA; Petsko GA; Fuller RS; Ringe D
    Biochemistry; 2003 Jun; 42(22):6709-18. PubMed ID: 12779325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteolytic cleavages of proalbumin and complement Pro-C3 in vitro by a truncated soluble form of furin, a mammalian homologue of the yeast Kex2 protease.
    Oda K; Misumi Y; Ikehara Y; Brennan SO; Hatsuzawa K; Nakayama K
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1353-61. PubMed ID: 1482351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoproteolytic processing of recombinant proalbumin variants by the yeast Kex2 protease.
    Ledgerwood EC; George PM; Peach RJ; Brennan SO
    Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):321-5. PubMed ID: 7755581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interplay between S1 and S4 subsites in Kex2 protease: Kex2 exhibits dual specificity for the P4 side chain.
    Rockwell NC; Fuller RS
    Biochemistry; 1998 Mar; 37(10):3386-91. PubMed ID: 9521659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Structure and properties of proprotein convertase inhibitors].
    Kibirev VK; Osadchuk TV
    Ukr Biokhim Zh (1999); 2012; 84(2):5-29. PubMed ID: 22642118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posttranslational processing of the prohormone-cleaving Kex2 protease in the Saccharomyces cerevisiae secretory pathway.
    Wilcox CA; Fuller RS
    J Cell Biol; 1991 Oct; 115(2):297-307. PubMed ID: 1918142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proprotein processing activity and cleavage site selectivity of the Kex2-like endoprotease PACE4.
    Creemers JW; Groot Kormelink PJ; Roebroek AJ; Nakayama K; Van de Ven WJ
    FEBS Lett; 1993 Dec; 336(1):65-9. PubMed ID: 8262218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The synthesis of inhibitors for processing proteinases and their action on the Kex2 proteinase of yeast.
    Angliker H; Wikstrom P; Shaw E; Brenner C; Fuller RS
    Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):75-81. PubMed ID: 8328974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of peptidyl methylcoumarin esters as substrates and active-site titrants for the prohormone processing proteases Kex2 and PC2.
    Rockwell NC; Krysan DJ; Fuller RS
    Anal Biochem; 2000 May; 280(2):201-8. PubMed ID: 10790301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A C-terminal domain conserved in precursor processing proteases is required for intramolecular N-terminal maturation of pro-Kex2 protease.
    Gluschankof P; Fuller RS
    EMBO J; 1994 May; 13(10):2280-8. PubMed ID: 8194519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KEX2 influences Candida albicans proteinase secretion and hyphal formation.
    Newport G; Agabian N
    J Biol Chem; 1997 Nov; 272(46):28954-61. PubMed ID: 9360967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A family of Kex2-like endoproteases involved in processing of precursors for biologically active peptides and proteins].
    Nakayama K
    Seikagaku; 1995 Aug; 67(8):995-1009. PubMed ID: 7594874
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative study of the binding pockets of mammalian proprotein convertases and its implications for the design of specific small molecule inhibitors.
    Tian S; Jianhua W
    Int J Biol Sci; 2010 Feb; 6(1):89-95. PubMed ID: 20151049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative assessment of enzyme specificity in vivo: P2 recognition by Kex2 protease defined in a genetic system.
    Bevan A; Brenner C; Fuller RS
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10384-9. PubMed ID: 9724712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7.
    Lissitzky JC; Luis J; Munzer JS; Benjannet S; Parat F; Chrétien M; Marvaldi J; Seidah NG
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):133-8. PubMed ID: 10657249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative characterization of furin specificity. Energetics of substrate discrimination using an internally consistent set of hexapeptidyl methylcoumarinamides.
    Krysan DJ; Rockwell NC; Fuller RS
    J Biol Chem; 1999 Aug; 274(33):23229-34. PubMed ID: 10438496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of PC2, a mammalian Kex2 homologue, following expression of the cDNA in microinjected Xenopus oocytes.
    Shennan KI; Smeekens SP; Steiner DF; Docherty K
    FEBS Lett; 1991 Jun; 284(2):277-80. PubMed ID: 2060650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pro-region of the Kex2 endoprotease of Saccharomyces cerevisiae is removed by self-processing.
    Germain D; Dumas F; Vernet T; Bourbonnais Y; Thomas DY; Boileau G
    FEBS Lett; 1992 Mar; 299(3):283-6. PubMed ID: 1544507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of K225 residue to the catalytic efficiency of Kex2 protease.
    Yang F; Liu L; Liu Y; Li S
    Protein Expr Purif; 2020 Dec; 176():105725. PubMed ID: 32800900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The proprotein convertase SKI-1/S1P. In vitro analysis of Lassa virus glycoprotein-derived substrates and ex vivo validation of irreversible peptide inhibitors.
    Pasquato A; Pullikotil P; Asselin MC; Vacatello M; Paolillo L; Ghezzo F; Basso F; Di Bello C; Dettin M; Seidah NG
    J Biol Chem; 2006 Aug; 281(33):23471-81. PubMed ID: 16790437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.